Clinical outcomes of carbon ion radiotherapy with concurrent chemotherapy for locally advanced uterine cervical adenocarcinoma in a phase 1/2 clinical trial (Protocol 1001) - Okonogi, Noriyuki; Wakatsuki, Masaru; Kato, Shingo; Karasawa, Kumiko; Kiyohara, Hiroki; Shiba, Shintaro; Kobayashi, Daijiro; Nakano, Takashi; Kamada, Tadashi; Shozu, Makio (Cancer medicine (Malden, MA), 2018)
Keywords: Adenocarcinoma; Adenocarcinoma, Clear Cell - pathology; Adenocarcinoma, Clear Cell - therapy; Adenocarcinoma, Mucinous - pathology; Adenocarcinoma, Mucinous - therapy; Adult; Aged; Antineoplastic Agents - therapeutic use; carbon ion radiotherapy; Carcinoma, Adenosquamous - pathology; Carcinoma, Adenosquamous - therapy; Cervical cancer; Chemoradiotherapy; Chemotherapy; cisplatin; Cisplatin - therapeutic use; Clinical Cancer Research; Clinical outcomes; Clinical trials; concurrent chemoradiotherapy; Endometrial Neoplasms - pathology; Endometrial Neoplasms - therapy; Female; Follow-Up Studies; Heavy Ion Radiotherapy; Humans; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Original Research; Radiation therapy; Survival Rate; Treatment Outcome; uterine cervical cancer; Uterine Cervical Neoplasms - pathology; Uterine Cervical Neoplasms - therapy; Young Adult; Adenocarcinoma; carbon ion radiotherapy; cisplatin; concurrent chemoradiotherapy; uterine cervical cancer